ArticleVeterinary and animal science2024
Potential of alginate, chitosan and polyethylene glycol as substances for colloidal drug delivery as determined by protein release and digestion.
Article in Veterinary and animal science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 4 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Colloidal encapsulations can be applied as protective matrices in aquaculture feeds. They promise an ideal approach to protect bioactive substances such as oral vaccines, pre- or probiotics against degradation due to acidic environments or untimely lixiviation. Alginate, chitosan and polyethylene glycol (PEG) are substances frequently applied in encapsulations as protective matrices. However, essential information on their direct and comparable characteristics and their effects on digestion speeds after oral application in aquaculture are lacking. The current study evaluated in vitro release and retention profiles of a model protein bovine serum albumin (BSA) after encapsulation with four experimental formulations of protective matrices: ALG - alginate; AC -alginate and chitosan, AP - alginate and PEG and APC - alginate, PEG and chitosan. The iron marked treatment diets were fed to juvenile rainbow trout and digestion speed was investigated using radiographic imaging. Digestion speeds did not differ significantly between treatments, with all test diets reaching the anterior fish intestine 10 h after feeding. The BSA retention under low pH was highest for the alginate-chitosan PM (84.7 ± 5.8 %). The inclusion of PEG reduced the retention rate in low pH but significantly increased the absolute BSA release. An oil coating significantly reduced the BSA release during the initial burst for the alginate, alginate-PEG and alginate-chitosan-PEG treatments and significantly reduced retention potential under neutral pH conditions. The feeding simulation trial showed that an oil-coated diet containing alginate-chitosan as a protective matrix can be used to protect the model protein during feeding (release to the water) and against the harmful milieu of the fish stomach. Different combinations of the investigated encapsulation substances can be used to achieve optimal encapsulation and protective characteristics depending on the application objective.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.